SCHEMBL1635875

SCHEMBL1635875

CCOP(=O)(OCC)Sc1cc(C(=O)NCC(=O)O)ccc1OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.50
PDE4B Q07343 1/20 0.50
PDE4C Q08493 1/20 0.50
PDE4D Q08499 1/20 0.50
SMN1; SMN2 Q16637 4/20 0.44
KMT2A Q03164 2/20 0.44
TP53 P04637 2/20 0.44
MEN1 O00255 1/20 0.44
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 1/20 0.43
HPGD P15428 1/20 0.43
POLB P06746 1/20 0.43
NR1H4 Q96RI1 1/20 0.42
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
GAA P10253 1/20 0.41
HTT P42858 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
MAPT P10636 1/20 0.40
LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1636167 0.89 PDE4A (0.53) PDE4APDE4BPDE4CPDE4DSMN1; SMN2
SCHEMBL1634932 0.88 NPC1 (0.49) PDE4APDE4BPDE4CPDE4DSMN1; SMN2
SCHEMBL1635174 0.85 PDE4A (0.54) PDE4APDE4BPDE4CPDE4DSMN1; SMN2
SCHEMBL1635068 0.80 PDE4A (0.59) PDE4APDE4BPDE4CPDE4DSMN1; SMN2
SCHEMBL1635281 0.79 L3MBTL1 (0.50) KMT2AALDH1A1KDM4EGAAHTT
SCHEMBL8178988 0.77 PDE4A (0.71) PDE4APDE4BPDE4CPDE4DSMN1; SMN2
SCHEMBL15572275 0.76 TSHR (0.67) PDE4APDE4BPDE4CPDE4DSMN1; SMN2
SCHEMBL1635889 0.75 PDE4A (0.62) PDE4APDE4BPDE4CPDE4DSMN1; SMN2
SCHEMBL15968774 0.73 PDE4A (0.60) PDE4APDE4BPDE4CPDE4DSMN1; SMN2
SCHEMBL1636586 0.73 CA5A (0.39) SMN1; SMN2ALDH1A1NPC1RAB9AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3138832-A1 SUBSTITUTED PHENOXY- AND PHENYLTHIO- DERIVATIVES FOR TREATING PROLIFERATIVE DISORDERS Temple University - Of The Commonwealth System of Higher Education (US) 2017-03-08 EP disclosed
US-7932242-B2 Anticancer agents; radiation and chemical resistance TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2011-04-26 US disclosed
US-20080058290-A1 Substituted Phenoxy-and Phenylthio-Derivatives for Treating Proliferative Disorders TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2008-03-06 US disclosed
EP-1740530-A4 SUBSTITUTED PHENOXY- AND PHENYLTHIO- DERIVATIVES FOR TREATING PROLIFERATIVE DISORDERS UNIV TEMPLE (US) 2008-02-27 EP disclosed
EP-1740530-A2 SUBSTITUTED PHENOXY- AND PHENYLTHIO- DERIVATIVES FOR TREATING PROLIFERATIVE DISORDERS Temple University of the Commonwealth System of Higher Education (US) 2007-01-10 EP disclosed
WO-2005089269-A2 SUBSTITUTED PHENOXY- AND PHENYLTHIO- DERIVATIVES FOR TREATING PROLIFERATIVE DISORDERS TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2005-09-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058290-A1 Substituted Phenoxy-and Phenylthio-Derivatives for Treating Proliferative Disorders PCNA, MKI67, TP53 PDE4A 4197/4885PDE4B 4316/4885PDE4C 4677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.